Skeletal Muscle Channelopathies

Gene: SCN4A

Green List (high evidence)

SCN4A (sodium voltage-gated channel alpha subunit 4)
EnsemblGeneIds (GRCh38): ENSG00000007314
EnsemblGeneIds (GRCh37): ENSG00000007314
OMIM: 603967, Gene2Phenotype
SCN4A is in 17 panels

4 reviews

Fowzan ALKURAYA (King Faisal Specialist Hospital and Research Center)

Green List (high evidence)

Reported mutations tend to be missense rather than LOF. PLI is very low in ExAC, which also suggests a disease mechanism other than LOF or haploinsufficiency.
Created: 22 Feb 2017, 3:38 p.m.

Publications

Mode of pathogenicity
Other - please provide details in the comments

Variants in this GENE are reported as part of current diagnostic practice

Fowzan ALKURAYA (King Faisal Specialist Hospital and Research Center)

Green List (high evidence)

Reported mutations tend to be missense rather than LOF. PLI is very low in ExAC, which also suggests a disease mechanism other than LOF or haploinsufficiency.
Created: 22 Feb 2017, 3:31 p.m.

Publications

Mode of pathogenicity
Other - please provide details in the comments

Variants in this GENE are reported as part of current diagnostic practice

Arianna Tucci (Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square)

Green List (high evidence)

Mostly missense mutations. two common path mutations: T704M and M1592V (periodic paralysis). A founder mutation (M1476I) in families with paramyotonia congenita.
Reduced penetrance.
Created: 10 Jan 2017, 3 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Hyperkalemic periodic paralysis, type 2; Hypokalemic periodic paralysis, type 2; Myotonia congenita, atypical, acetazolamide-responsive; Paramyotonia congenita

Publications

Ellen McDonagh (Genomics England Curator)

Is on the Muscle Channel NGS Panel in the UCLH National Hospital for Neurology and Neurosurgery & Institute of Neurology (NHNN) Neurogenetics genetic testing manual.
Created: 10 Jun 2016, 2:47 p.m.
Comment on mode of inheritance: Confirmed on OMIM.
Created: 10 Jun 2016, 2:28 p.m.
Comment on list classification: This gene is in the genetic muscle channel diseases section in the UCLH National Hospital for Neurology and Neurosurgery & Institute of Neurology (NHNN) Neurogenetics genetic testing manual, for testing of Paramyotonia Congenita, one of the main skeletal muscle channelopathies.
Created: 10 Jun 2016, 2:26 p.m.

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Eligibility statement prior genetic testing
  • UKGTN
  • Illumina TruGenome Clinical Sequencing Services
  • Radboud University Medical Center, Nijmegen
Phenotypes
  • Hyperkalemic periodic paralysis, type 2, 170500
  • Myasthenic syndrome, acetazolamide-responsive, 614198
  • Hypokalemic periodic paralysis, type 2, 613
  • Potassium-Aggravated Myotonia
  • Hyperkalemic Periodic Paralysis
  • Hypokalemic Periodic Paralysis
  • Thyrotoxic Periodic Paralysis, Susceptibility To, 2
  • Myotonia
  • Episodic weakness
OMIM
603967
Clinvar variants
Variants in SCN4A
Penetrance
Incomplete
Publications
Panels with this gene

History Filter Activity

22 Feb 2017, Gel status: 4

panel promoted to version 1

Arianna Tucci (Genomics England Curator)

Promoted 22/02/2017 after curation discussion and further review with members of the Genomics England curation team.

2 Feb 2017, Gel status: 4

Gene classified by Genomics England curator

Arianna Tucci (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

2 Feb 2017, Gel status: 4

Set Phenotypes

Arianna Tucci (Genomics England Curator)

Phenotypes for SCN4A were set to Hyperkalemic periodic paralysis, type 2, 170500; Myasthenic syndrome, acetazolamide-responsive, 614198; Hypokalemic periodic paralysis, type 2, 613; Potassium-Aggravated Myotonia; Hyperkalemic Periodic Paralysis; Hypokalemic Periodic Paralysis; Thyrotoxic Periodic Paralysis, Susceptibility To, 2; Myotonia; Episodic weakness

2 Feb 2017, Gel status: 4

Set publications

Arianna Tucci (Genomics England Curator)

Publications for SCN4A were set to 17395131; 15534250

2 Feb 2017, Gel status: 4

Set Mode of Inheritance

Arianna Tucci (Genomics England Curator)

Mode of inheritance for SCN4A was changed to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

2 Feb 2017, Gel status: 4

Set Phenotypes

Arianna Tucci (Genomics England Curator)

Phenotypes for gene SCN4A were set to Hyperkalemic periodic paralysis, type 2, 170500; Myasthenic syndrome, acetazolamide-responsive, 614198; Hypokalemic periodic paralysis, type 2, 613; Potassium-Aggravated Myotonia; Hyperkalemic Periodic Paralysis; Hypokalemic Periodic Paralysis; Thyrotoxic Periodic Paralysis, Susceptibility To, 2;Myotonia; Episodic weakness

10 Jun 2016, Gel status: 4

Set Mode of Inheritance

Ellen McDonagh (Genomics England Curator)

Mode of inheritance for SCN4A was changed to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

10 Jun 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

12 Aug 2015, Gel status: 3

Added New Source

Ellen McDonagh (Genomics England Curator)

SCN4A was added to Skeletal Muscle Channelopathiespanel. Sources: Eligibility statement prior genetic testing

7 Aug 2015, Gel status: 3

Added New Source

Eik Haraldsdottir (Genomics England)

SCN4A was added to Skeletal Muscle Channelopathiespanel. Sources: UKGTN

7 Aug 2015, Gel status: 2

Set Mode of Inheritance

Eik Haraldsdottir (Genomics England)

Model of inheritance for gene SCN4A was changed to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

7 Aug 2015, Gel status: 2

Added New Source

Eik Haraldsdottir (Genomics England)

SCN4A was added to Skeletal Muscle Channelopathiespanel. Sources: Illumina TruGenome Clinical Sequencing Services

7 Aug 2015, Gel status: 1

Added New Source

Eik Haraldsdottir (Genomics England)

SCN4A was added to Skeletal Muscle Channelopathiespanel. Sources: Radboud University Medical Center, Nijmegen